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Chagas Disease: “The Kiss of Death” 
By:  Jessica Rogers and Stacy Castro 
Presented at the Nacogdoches Independent School District Board of Trustees meeting on February 19, 2015.                                                References available upon request. 
Micro Organism 
Chagas disease is a vector transmitted disease also known as American 
trypanosomiasis. Chagas disease is classified as a protist or protozoa, which is a 
simplified version of  ‘animal-like single celled organism that is like a 
multicellular organism’. This is because of the trypanosoma cruzi which is the 
protist itself  (U.S. National Library of Medicine, 2012). This disease’s life cycle is 
complicated. The trypanosoma cruzi changes forms in its life cycle as it travels 
from hosts. The disease is first transmitted by the vector as it takes a blood meal. 
This is where the disease then takes over the cells near the wound cite. The disease 
grows, multiplying by using binary fission and the infected cell tissue. During the 
third stage the disease bursts into the blood stream where a new vector takes a 
blood meal, digesting the disease. The microorganism multiplies within the 
vector’s body and the cycle repeats (CDC, 2013). The vector, commonly referred 
to as the ‘Kissing Bug’ is a black and orange striped insect the size of a penny -20 
mm.   
 Importance 
Chagas disease  is found primarily in Latin America, but has slowly traveled 
throughout Southern North America. Due to this disease’s growth, it can be 
considered common to south Texas and is easily becoming just as popular 
throughout the whole state.  Because we ourselves live in Texas, caution towards 
the disease is strongly advised (Texas Department of State Health Services, 2012). 
However just because the disease cuts close to home is not the sole reason to 
worry; the fact that ‘if you discover you have the disease in the chronic stages you 
will perish’ is another reason to be wary. It is also important to understand Chagas 
disease because it is one of the major health problems in South  America. 
Historical 
 Chagas disease was discovered by Carlos Chagas in 1909. He was the first to discover 
the aspects of the disease and so was named after him. The Chagas disease is a form 
of African sleeping sickness, and vice versa. (Archive, 2014). Disease vectors have 
been transferring this disease among mammals for over five million years, 
however the oldest record of the disease is 9,000 years old. Currently this is 
viewed as a crucial disease considering the fact you are deemed hopeless if you are 
not treated during the beginning stages. Using that information, one can infer that 
considering today’s technologies and sciences available, long ago this disease was 
not survivable. 
Immune Response 
In the human immune system there are three lines of defense against attack. 
The first line of defense is a nonspecific defense consisting of multiple 
layers of skin, mucus, and cilia. The second line of defense is also 
nonspecific, but less so than the first. In the second line of defense the 
macrophages attack the pathogens, ‘eating’ them, while the white blood 
cells destroy invading pathogens. Also the body increases its temperature 
into a fever causing an inflammation to occur. Unlike the other two, the 
third line of defense is specific. B cells send out antibodies to attach to the 
disease causing organisms so that the macrophage find and consume them 
easier. Helper T cells boost the fighting cells and send signals to give 
instructions. Then memory T cells “remember” the attacking pathogen so 
the body can respond quicker the next time it is invaded with the same 
organism (Nogueira, L. G., & Cunha-Neto, 2009). 
Progression 
Progression of Chagas disease with treatment in the acute phases of the 
disease will most commonly yield 100% curability. However after the acute 
stages of Chagas disease the percent rate of survivability and curability 
decreases and the treatment process becomes prolonged. Chagas disease 
also often yields no symptoms or signs that someone has the disease in the 
first stages. However the chronic stages show the heart failure and other 
symptoms (Mayo Clinic, 2014). 
Prognosis 
If a patient is diagnosed with Chagas disease immediate treatment is 
strongly advised. The longer the patient has the disease the less likely the 
treatment will work. If a patient reaches the chronic stages he or she will 
most likely perish (Mayo Clinic, 2014). Luckily Chagas disease will not 
reoccur if you already have it. This is because most who catch the disease 
either cannot afford the treatment and die for that reason or because they 
have already reached the chronic stages and have died, or because they 
reached treatment and  were cured. However,  Chagas disease does seem to 
‘reoccur’ due to the fact that after the acute phases pass,  the disease it will 
lay dormant for days, months, or even years. Then suddenly the chronic 
stages will re-emerge (Mayo Clinic, 2014).  
Options 
There are only two options for the treatment of Chagas disease, nifurtimox 
and benznidazole, which are prescribed during the acute phases. Both 
nifurtimox and benznidazole target the protozoa, and can cause some 
serious side effects. If a treatment is missed, health professionals warn 
patients no to take a double dose-that amount of strong medication could 
lead to some serious altercations.  However this is not where troubles begin; 
troubles start at how to acquire the drugs since it is not commercially 
available in the United States or Canada (Drugs.com, 2015). 
Mechanism 
The two drugs, nifurtimox and benznidazole, both attack the pathogen. The 
mechanism by which this is done by each varies greatly. Nifurtimox targets 
the deoxyribonucleic acid or DNA, of the pathogen .  Benznidazole targets 
the ribonucleic acid or RNA, of the pathogen (Drugs.com ,2015). However 
not much more is known about benznidazole, and it is expected to be 
studied relatively soon, while nifurtimox is known so well that scientist 
even know how this drug is specifically removed. 
Emerging 
The World Health Organization (WHO) has been alerted about Chagas 
disease and has decided to find a more efficient treatment.  Also, Drugs for 
Neglected Diseases (DND) has started an initiative to build a strong case for 
Chagas disease in order to raise awareness of the severity of the disease. 
Drugs for Neglected Disease also hopes to create a non-expensive treatment 
for the disease in order for all classes to afford it. This emerging treatment 
will not just be for the acute stages like the two drugs already in use. It will 
be for all stages of Chagas disease. Therefore there is much hope for the 
new DND treatment to be released to the public as an official treatment 
drug, as well as the WHO effort to create one as well. There are many 
smaller projects for treatment emerging for CD, but the main one will be 
focused on. This main treatment is the DND’s; it is the most promising of 
all the projects and will most likely yield a product of the high-standards it 
boasts (World Health Organization, 2014; Pan American Health 
Organization, 2013). 
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